Anticancer hybrids--a patent survey.

Area of Science:

• Medicinal Chemistry
• Drug Design
• Pharmacology

Background:

• Molecular hybridization (MH) is a rational drug design strategy.
• It involves fusing pharmacophoric subunits from known bioactive molecules.
• This creates novel hybrid architectures with retained or enhanced properties.

Purpose of the Study:

• To review potent hybrid structures reported over the last two decades.
• To provide a detailed account of the relevant patent literature.
• To guide medicinal chemists in the field of hybrid drug design.

Main Methods:

• Comprehensive literature search for potent hybrid structures.
• Analysis of patent literature related to molecular hybridization.
• Compilation of IC50/GI50 values against various cell lines.

Main Results:

• Significant patent activity indicates global research focus on hybrid molecules.
• Hybrid molecules offer potential for amplified effects or multi-target interactions.
• This approach can reduce drug-drug interactions and minimize drug resistance.

Conclusions:

• Molecular hybridization is a key strategy in modern drug discovery.
• The reviewed hybrids and patent landscape offer valuable insights.
• This compilation serves as a guide for developing next-generation therapeutics.